By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Collegium Pharmaceutical, Inc. 

400 Highland Corporate Drive

Cumberland  Rhode Island  02864  U.S.A.
Phone: 401-762-2000 Fax: 401-762-2043



Company News
FDA Panel Gives Green Light to Collegium (COLL)'s Painkiller Xtampza ER 9/14/2015 9:38:18 AM
Collegium (COLL) To Present Highlights From Xtampza ER (Oxycodone Extended-Release Capsules) Clinical Development Program At Painweek 9/4/2015 7:22:56 AM
Collegium (COLL) Publishes Data From Xtampza ER Phase III Clinical Trial In The Journal PAIN 8/24/2015 7:45:31 AM
Collegium (COLL) Reports Second Quarter Financial Results And Provides Corporate Update 8/13/2015 11:58:49 AM
Collegium (COLL) To Host Conference Call To Discuss Financial Results And Provide Corporate Update 8/7/2015 10:46:40 AM
Collegium (COLL) Announces FDA Advisory Committee Meeting For Xtampza ER, An Abuse-Deterrent Analgesic For Chronic Pain 8/7/2015 8:06:33 AM
Collegium (COLL) Added To Russell 2000, 3000 And Global Indexes 7/7/2015 7:06:15 AM
Collegium (COLL) Expands Leadership Team With Vice President Of Regulatory Affairs And Quality Assurance 7/1/2015 7:15:02 AM
Collegium (COLL) Announces Publication of "Comparing the Effect Of Tampering On The Oral Pharmacokinetic Profiles Of Two Extended-Release Oxycodone Formulations With Abuse-Deterrent Properties," In Pain Medicine 6/25/2015 6:41:52 AM
Collegium (COLL) To Present Xtampza ER Oral Human Abuse Potential Data At The College On Problems Of Drug Dependence 77th Annual Meeting 6/15/2015 2:13:38 PM